LOXO-101 Holds Promise as Potential Treatment Targeting Solid Tumors

A recent announcement from the University of Texas MD Anderson Cancer Center described a study that shows promise for a potential treatment (LOXO-101) that targets solid tumors with NTRK gene fusions. The investigational agent, [...]